P

Phio Pharmaceuticals Corp
D

PHIO

2.20000
USD
-0.04
(-1.79%)
Market Open
Volume
1,243
EPS
0
Div Yield
0
P/E
-0
Market Cap
1,893,586
OverviewSignalsIdeasNews
Related Instruments
    A
    ATAI
    -0.14000
    (-8.97%)
    1.42000 USD
    B
    BNTC
    -0.46000
    (-5.34%)
    8.15000 USD
    B
    BVXV
    0.06000
    (4.58%)
    1.37000 USD
    C
    CGEM
    -0.590
    (-3.04%)
    18.790 USD
    C
    CLRB
    -0.10000
    (-4.65%)
    2.05000 USD
    E
    EOLS
    1.660
    (13.38%)
    14.070 USD
    I
    IMMP
    -0.09500
    (-4.39%)
    2.07000 USD
    P
    PRQR
    -0.10000
    (-5.24%)
    1.81000 USD
    R
    RXRX
    -0.87500
    (-10.66%)
    7.33500 USD
    More
News

Title: Phio Pharmaceuticals Corp

Sector: Healthcare
Industry: Biotechnology
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.